Boosting Biopharma Confidence with Cutting-Edge Tools

BIOT

featured image of Boosting Biopharma Confidence with Cutting-Edge Tools
🧪 Charles River Laboratories offers tools and services for biopharma companies to efficiently produce and test cell, gene, and gene-modified cell therapy products.
🔬 These tools include reference materials for adeno-associated viruses and lentiviral vectors, which can be used for assay development and validation.
🧬 They also offer a technology transfer framework for viral vectors and a Flex Platform for cell therapy development.
💪 These solutions accelerate the development of new therapies and ensure consistency and confidence for biopharma companies.
📢 Boost Your Biopharma Confidence with Charles River

Introduction:

Biopharma companies often rely on contract development and manufacturing organizations (CDMOs) for the production of materials for clinical trials and manufacturing therapies. Charles River Laboratories, a veteran CRO and CDMO, offers a suite of tools and services to support biopharma companies throughout the drug discovery and development process. They have developed reference materials for adeno-associated viruses (AAV) and lentiviral vectors (LVV) to ensure safety and efficacy testing, as well as a framework for technology transfer of viral vectors. Additionally, they have launched the Flex Platform for CAR T and TCR T cells, providing a modular and flexible solution for cell therapy development.

Main points:

  1. Charles River Laboratories offers tools and services to support biopharma companies in the production and testing of cell, gene, and gene-modified cell therapy products.
  2. They have developed reference materials for AAV and LVV to assist with safety and efficacy testing.
  3. Charles River has launched a framework for technology transfer of viral vectors, facilitating program continuity and de-risking supply chains.
  4. The company has introduced the Flex Platform for CAR T and TCR T cells, providing a modular and flexible solution for cell therapy development.
  5. These tools and services aim to accelerate and improve the development of drug therapies and support the growing demand for gene-modified cell therapies.

Conclusion:

Charles River Laboratories offers a comprehensive suite of tools and services to support biopharma companies in the development and manufacturing of cell, gene, and gene-modified cell therapy products. Their reference materials, technology transfer framework, and Flex Platform contribute to the acceleration and improvement of drug therapies, ensuring consistency and confidence for biopharma companies.

Leave a Comment